JOHNSON CONTROLS INTERNATION (JCI)

IE00BY7QL619 - Common Stock

80.21  +0.91 (+1.15%)

After market: 80.21 0 (0%)

Fundamental Rating

3

JCI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Building Products industry. JCI has a medium profitability rating, but doesn't score so well on its financial health evaluation. JCI has a expensive valuation and it also scores bad on growth.



4

1. Profitability

1.1 Basic Checks

JCI had positive earnings in the past year.
JCI had a positive operating cash flow in the past year.
In the past 5 years JCI has always been profitable.
Each year in the past 5 years JCI had a positive operating cash flow.

1.2 Ratios

JCI has a worse Return On Assets (3.99%) than 70.00% of its industry peers.
JCI has a Return On Equity of 10.59%. This is in the lower half of the industry: JCI underperforms 60.00% of its industry peers.
With a Return On Invested Capital value of 6.02%, JCI is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for JCI is significantly below the industry average of 13.18%.
Industry RankSector Rank
ROA 3.99%
ROE 10.59%
ROIC 6.02%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%

1.3 Margins

Looking at the Profit Margin, with a value of 7.43%, JCI is in line with its industry, outperforming 45.00% of the companies in the same industry.
JCI's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 10.53%, JCI is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of JCI has grown nicely.
JCI's Gross Margin of 35.19% is in line compared to the rest of the industry. JCI outperforms 52.50% of its industry peers.
JCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.53%
PM (TTM) 7.43%
GM 35.19%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%

2

2. Health

2.1 Basic Checks

JCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for JCI has been reduced compared to 1 year ago.
Compared to 5 years ago, JCI has less shares outstanding
JCI has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 1.93 indicates that JCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of JCI (1.93) is worse than 82.50% of its industry peers.
The Debt to FCF ratio of JCI is 5.94, which is a neutral value as it means it would take JCI, 5.94 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.94, JCI is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.56 indicates that JCI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.56, JCI perfoms like the industry average, outperforming 52.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.94
Altman-Z 1.93
ROIC/WACC0.89
WACC6.78%

2.3 Liquidity

JCI has a Current Ratio of 0.94. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
JCI has a worse Current ratio (0.94) than 92.50% of its industry peers.
JCI has a Quick Ratio of 0.94. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
JCI has a worse Quick ratio (0.79) than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.79

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.00% over the past year.
Measured over the past years, JCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
JCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.34%.
JCI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.86% yearly.
EPS 1Y (TTM)6%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%21.9%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-9.49%

3.2 Future

JCI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.68% yearly.
JCI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y-3.3%
EPS Next 2Y5.82%
EPS Next 3Y9.69%
EPS Next 5Y9.68%
Revenue Next Year-10.72%
Revenue Next 2Y-3.76%
Revenue Next 3Y-0.73%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.62, which indicates a rather expensive current valuation of JCI.
Compared to the rest of the industry, the Price/Earnings ratio of JCI is on the same level as its industry peers.
JCI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 22.36, the valuation of JCI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, JCI is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
JCI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.53.
Industry RankSector Rank
PE 21.62
Fwd PE 22.36

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than 62.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, JCI is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 33.24
EV/EBITDA 18.89

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2Y5.82%
EPS Next 3Y9.69%

6

5. Dividend

5.1 Amount

JCI has a Yearly Dividend Yield of 1.85%.
JCI's Dividend Yield is rather good when compared to the industry average which is at 1.10. JCI pays more dividend than 95.00% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.33, JCI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

On average, the dividend of JCI grows each year by 6.63%, which is quite nice.
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
As JCI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.63%
Div Incr Years3
Div Non Decr Years6

5.3 Sustainability

JCI pays out 58.65% of its income as dividend. This is a bit on the high side, but may be sustainable.
JCI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.65%
EPS Next 2Y5.82%
EPS Next 3Y9.69%

JOHNSON CONTROLS INTERNATION

NYSE:JCI (1/14/2025, 8:04:00 PM)

After market: 80.21 0 (0%)

80.21

+0.91 (+1.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)01-31 2025-01-31/bmo
Inst Owners94.25%
Inst Owner Change-0.02%
Ins Owners0.34%
Ins Owner Change2.29%
Market Cap53.11B
Analysts76.43
Price Target90.28 (12.55%)
Short Float %1.46%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Dividend Growth(5Y)6.63%
DP58.65%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.92%
Min EPS beat(2)4.26%
Max EPS beat(2)5.59%
EPS beat(4)3
Avg EPS beat(4)2.87%
Min EPS beat(4)-0.74%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)0.8%
EPS beat(12)5
Avg EPS beat(12)0.36%
EPS beat(16)7
Avg EPS beat(16)0.84%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-13.77%
Max Revenue beat(2)-2.38%
Revenue beat(4)0
Avg Revenue beat(4)-4.7%
Min Revenue beat(4)-13.77%
Max Revenue beat(4)-1.19%
Revenue beat(8)1
Avg Revenue beat(8)-3.31%
Revenue beat(12)2
Avg Revenue beat(12)-2.73%
Revenue beat(16)4
Avg Revenue beat(16)-2.13%
PT rev (1m)1.21%
PT rev (3m)15.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.77%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)-9.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.99%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-11.33%
Valuation
Industry RankSector Rank
PE 21.62
Fwd PE 22.36
P/S 2.31
P/FCF 33.24
P/OCF 25.39
P/B 3.3
P/tB N/A
EV/EBITDA 18.89
EPS(TTM)3.71
EY4.63%
EPS(NY)3.59
Fwd EY4.47%
FCF(TTM)2.41
FCFY3.01%
OCF(TTM)3.16
OCFY3.94%
SpS34.66
BVpS24.31
TBVpS-7.18
PEG (NY)N/A
PEG (5Y)1.66
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 10.59%
ROCE 7.86%
ROIC 6.02%
ROICexc 6.14%
ROICexgc 18.65%
OM 10.53%
PM (TTM) 7.43%
GM 35.19%
FCFM 6.96%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.94
Debt/EBITDA 2.77
Cap/Depr 60.54%
Cap/Sales 2.15%
Interest Coverage 250
Cash Conversion 64.73%
Profit Quality 93.72%
Current Ratio 0.94
Quick Ratio 0.79
Altman-Z 1.93
F-Score5
WACC6.78%
ROIC/WACC0.89
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)6%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%21.9%
EPS Next Y-3.3%
EPS Next 2Y5.82%
EPS Next 3Y9.69%
EPS Next 5Y9.68%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-9.49%
Revenue Next Year-10.72%
Revenue Next 2Y-3.76%
Revenue Next 3Y-0.73%
Revenue Next 5Y3.16%
EBIT growth 1Y-13.4%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year12.4%
EBIT Next 3Y11.16%
EBIT Next 5Y8.77%
FCF growth 1Y-4.99%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y-5.81%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%